These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 10623598

  • 1. TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts.
    Chang NS.
    Biochem Biophys Res Commun; 2000 Jan 07; 267(1):194-200. PubMed ID: 10623598
    [Abstract] [Full Text] [Related]

  • 2. Suppression of IkappaBalpha expression is necessary for c-Jun N-terminal kinase-mediated enhancement of Fas cytotoxicity.
    Chang NS, Schultz L, Heath J.
    Biochem Biophys Res Commun; 2000 Jul 21; 274(1):4-10. PubMed ID: 10903887
    [Abstract] [Full Text] [Related]

  • 3. IkappaBalpha is essential for maintaining basal c-Jun N-terminal kinase (JNK) activation and regulating JNK-mediated resistance to tumor necrosis factor cytotoxicity in L929 cells.
    Chang NS.
    Biochem Biophys Res Commun; 1999 Sep 16; 263(1):107-12. PubMed ID: 10486261
    [Abstract] [Full Text] [Related]

  • 4. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 5. Hyaluronidase enhancement of TNF-mediated cell death is reversed by TGF-beta 1.
    Chang NS.
    Am J Physiol; 1997 Dec 22; 273(6):C1987-94. PubMed ID: 9435505
    [Abstract] [Full Text] [Related]

  • 6. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE.
    Oncogene; 2003 Jan 23; 22(3):412-25. PubMed ID: 12545162
    [Abstract] [Full Text] [Related]

  • 7. Kinase suppressor of Ras determines survival of intestinal epithelial cells exposed to tumor necrosis factor.
    Yan F, John SK, Polk DB.
    Cancer Res; 2001 Dec 15; 61(24):8668-75. PubMed ID: 11751383
    [Abstract] [Full Text] [Related]

  • 8. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB.
    J Biol Chem; 2004 Sep 17; 279(38):39541-54. PubMed ID: 15252041
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG.
    Oncogene; 2003 Jul 10; 22(28):4314-32. PubMed ID: 12853969
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.
    Chang NS.
    BMC Cell Biol; 2002 Apr 03; 3():8. PubMed ID: 11960552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
    Lee CW, Lin WN, Lin CC, Luo SF, Wang JS, Pouyssegur J, Yang CM.
    J Cell Physiol; 2006 Apr 03; 207(1):174-86. PubMed ID: 16288471
    [Abstract] [Full Text] [Related]

  • 14. Hyaluronidase activation of c-Jun N-terminal kinase is necessary for protection of L929 fibrosarcoma cells from staurosporine-mediated cell death.
    Chang NS.
    Biochem Biophys Res Commun; 2001 May 04; 283(2):278-86. PubMed ID: 11327694
    [Abstract] [Full Text] [Related]

  • 15. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
    Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB.
    J Immunol; 1999 Dec 15; 163(12):6800-9. PubMed ID: 10586080
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y, Culmsee C, Klumpp S, Krieglstein J.
    Neuroscience; 2004 Dec 15; 123(4):897-906. PubMed ID: 14751283
    [Abstract] [Full Text] [Related]

  • 17. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL, Krebs DL, Gold MR.
    J Immunol; 1999 Apr 15; 162(8):4720-30. PubMed ID: 10202013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.